NEW YORK (GenomeWeb) – Rosetta Genomics announced today that it will implement a cost-reduction plan that aims to initially trim its annual operating expenses by $1.7 million, primarily through layoffs and discretionary spending cuts.

Rosetta said that it would reduce employee and contractor headcount in both the US and Israel, but did not provide specific details about its plan such as the number of jobs that would be eliminated or exact areas of expense reduction.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Rare gene mutations are guiding the search for drugs to manage chronic pain without opioids, according to CNBC.

The new Francis Crick Institute building can get too noisy for some researchers to concentrate, according to the Guardian.

CBS News reports that there are still many vacancies at the White House Office of Science and Technology Policy, but that it's uncertain whether they will be filled.

In Nucleic Acids Research this week: pipeline to analyze and visualize bacterial genomes, database of global set of human genomes, and more.